LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.840
-0.050 (-2.65%)
Nov 7, 2024, 4:00 PM EST - Market closed
LAVA Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Jan '20 Jan 1, 2020 |
| Net Income | -24.18 | -41.97 | -31.91 | -42.36 | -15.93 | -9.69 |
| Depreciation & Amortization | 1.15 | 1.28 | 0.78 | 0.56 | 0.46 | 0.26 |
| Loss (Gain) From Sale of Investments | -2.35 | -1.9 | -0.13 | 0.45 | - | - |
| Stock-Based Compensation | 3.77 | 5.04 | 4.11 | 3.91 | 0.56 | 0.19 |
| Other Operating Activities | -0.29 | 1.41 | -2.92 | -2.04 | 0.87 | - |
| Change in Accounts Receivable | 3.4 | 1.87 | -2.89 | 0.78 | -1.07 | 0.04 |
| Change in Accounts Payable | -0.85 | 0.33 | 1.41 | 1.62 | 0.32 | -0.19 |
| Change in Unearned Revenue | - | - | 33.51 | -4.65 | 6.18 | - |
| Change in Other Net Operating Assets | -7.71 | -5.03 | 2.08 | 13.09 | -0.7 | 0.77 |
| Operating Cash Flow | -27.08 | -38.97 | 4.04 | -28.65 | -9.31 | -8.62 |
| Capital Expenditures | -0.01 | -0.73 | -0.59 | -0.76 | -0.5 | -0.76 |
| Investment in Securities | -24.57 | -16.91 | 9.93 | -42.78 | - | -0.03 |
| Investing Cash Flow | -24.48 | -17.64 | 9.35 | -43.55 | -0.5 | -0.79 |
| Long-Term Debt Issued | - | 0.47 | 0.61 | 0.68 | 2.03 | 1.27 |
| Long-Term Debt Repaid | - | -1.04 | -0.34 | -0.34 | -0.24 | -0.1 |
| Net Debt Issued (Repaid) | -0.34 | -0.57 | 0.27 | 0.34 | 1.79 | 1.18 |
| Issuance of Common Stock | 0.03 | - | 0.02 | 94.19 | - | - |
| Financing Cash Flow | -0.31 | -0.57 | 0.28 | 151.16 | 18.97 | 1.18 |
| Foreign Exchange Rate Adjustments | -0.65 | 1.08 | -4.21 | -3.92 | -0.68 | -0.43 |
| Net Cash Flow | -52.52 | -56.1 | 9.46 | 75.05 | 8.48 | -8.66 |
| Free Cash Flow | -27.09 | -39.7 | 3.46 | -29.41 | -9.81 | -9.38 |
| Free Cash Flow Margin | -366.14% | -586.53% | 17.82% | -549.74% | -261.78% | - |
| Free Cash Flow Per Share | -1.00 | -1.49 | 0.13 | -1.49 | -24.58 | -20.95 |
| Levered Free Cash Flow | -17.98 | -24.82 | -15.88 | -20.99 | -5.05 | - |
| Unlevered Free Cash Flow | -17.98 | -24.82 | -15.88 | -20.6 | -4.83 | - |
| Change in Net Working Capital | 5.71 | 3.38 | -1.59 | -2.96 | -3.82 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.